Global private equity firms Blackstone, Brookfield and Warburg Pincus are in talks to acquire a majority stake in Hyderabad-based Gland Pharma Ltd from China’s Shanghai Fosun Pharmaceutical Co. Ltd in a deal expected to...
Alkem Laboratories makes twin acquisitions
Alkem Laboratories Ltd has announced the acquisition of Adroit Biomed, a dermatology and cosmetology-focused company, and Bombay Ortho Industries, a medical technology firm, in two separate deals. The acquisitions will...
Avendus Future Leaders Fund picks minority stake in La Renon for Rs 160 crore
Avendus Future Leaders Fund (FLF), the flagship private strategies fund of the Avendus Group, on Tuesday said it has taken a minority stake in Ahmedabad-based drugmaker La Renon Healthcare for Rs 160 crore. Avendus FLF...
Jubilant Pharmova announces acquisition of 80% stake in JASMIN
Through its step-down subsidiary – Jubilant Biosys Innovative Research Services, Singapore Jubilant Biosys Innovative Research Services, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys, a wholly owned...
CCI clears merger of nine pharma entities with Sequent Scientific
The Competition Commission on Tuesday cleared the proposed amalgamation of nine entities with pharmaceutical firm Sequent Scientific Ltd (SSL). “The proposed combination involves a series of inter-connected steps...
French firm Roquette seeks CCI’s clearance for IFF Pharma’s biz acquisition
French plant-based ingredient producer Roquette Frres has sought fair trade regulator CCI’s approval for the proposed acquisition of the pharma solutions business and certain product lines of International Flavors...
Sun Pharma’s unit Taro to acquire 100% stake in Antibe Therapeutics
Sun Pharmaceutical has announced that its subsidiary, Taro Pharmaceuticals, has entered into an agreement to acquire a 100 per cent stake in Antibe Therapeutics, a clinical-stage biotechnology company based in Ontario...
J&J to acquire psychiatric drugs maker Intra-Cellular for $14.6 billion
Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc, a company focused on treatments for central nervous system disorders, for about $14.6 billion. J&J will pay $132 a share, the company said in a...
GSK to buy US biotech firm IDRx for up to $1.15 billion
British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of tumour. IDRx, a privately held biotechnology...
J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports
Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies, a biopharmaceutical company, Bloomberg News reported on Sunday, citing people familiar with the matter. Intra-Cellular has a...
Asset management firm DBAY to buy UK’s Alliance Pharma in $430 million deal
Britain’s Alliance Pharma said on Friday it has agreed to be acquired by asset management firm DBAY Advisors in an all-cash deal valuing the healthcare group at 349.7 million pounds ($429.6 million). The 62.5...
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics, a specialist in complex immune cell therapies to treat several types of blood cancer. Roche said it has...
